Leading the Way in Cancer Detection, Treatment, and Prevention: The Center for BRCA and Related Genes
Mutations in BRCA (BReast CAncer) genes can be passed down from generation to generation, increasing the risk of developing breast cancer, as well as ovarian, pancreatic and prostate cancers. Heritable BRCA mutations or mutations emerging in the tumors determine the tumor biology; this knowledge has been used to design effective and highly targeted therapies.
Join the leaders of Dana-Farber's Center for BRCA and Related Genes - one of the few dedicated BRCA centers worldwide - to learn how they are working to expand genetic testing for mutations, detect BRCA-related cancers earlier, and develop new therapies for patients with inherited and acquired mutations. Dana-Farber Trustee Michael Eisenson, Chair of the Dana-Farber Campaign, will host the complimentary educational webinar, which will include a live, interactive session for your questions.